Journal of Tuberculosis and Lung Disease ›› 2024, Vol. 5 ›› Issue (1): 44-50.doi: 10.19983/j.issn.2096-8493.20230085
• Original Articles • Previous Articles Next Articles
Xue Jianhang, Cao hong, Li Lu, Liu Xunrui, Ma Guilin, Zheng Rongrong, Ke Ran()
Received:
2023-08-04
Online:
2024-02-20
Published:
2024-02-02
Contact:
Ke Ran,Email: CLC Number:
Xue Jianhang, Cao hong, Li Lu, Liu Xunrui, Ma Guilin, Zheng Rongrong, Ke Ran. Analysis of treatment outcome and influencing factors of 308 patients with multidrug-resistant pulmonary tuberculosis[J]. Journal of Tuberculosis and Lung Disease , 2024, 5(1): 44-50. doi: 10.19983/j.issn.2096-8493.20230085
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.jtbld.cn/EN/10.19983/j.issn.2096-8493.20230085
影响因素 | 全部患者 | 发生不良转归 | 未发生不良转归 | χ2值 | P值 |
---|---|---|---|---|---|
性别 | 13.249 | <0.001 | |||
男性 | 222(72.08) | 71(31.98) | 151(68.02) | ||
女性 | 86(27.92) | 15(17.44) | 71(82.56) | ||
年龄组(岁) | 6.380 | 0.012 | |||
≥50 | 78(25.32) | 29(37.18) | 49(62.82) | ||
<50 | 230(74.68) | 52(22.61) | 178(77.39) | ||
职业分类 | 20.656 | <0.001 | |||
家务及待业 | 158(51.30) | 24(15.19) | 134(84.81) | ||
其他职业 | 150(48.70) | 57(38.00) | 93(62.00) | ||
登记分类 | 15.968 | <0.001 | |||
复治 | 251(81.49) | 78(31.08) | 173(68.92) | ||
初治 | 57(18.51) | 3(5.26) | 54(94.74) | ||
治疗模式 | 4.292 | 0.038 | |||
住院治疗 | 191(62.01) | 58(30.37) | 133(69.63) | ||
门诊治疗 | 117(37.99) | 23(19.66) | 94(80.34) | ||
人群分类 | 1.983 | 0.159 | |||
流动人口 | 225(73.05) | 64(28.44) | 161(71.56) | ||
本地居民 | 83(26.95) | 17(20.48) | 66(79.52) | ||
3个月末痰培养阴性 | 156.670 | <0.001 | |||
是 | 221(71.75) | 15(6.79) | 206(93.21) | ||
否 | 87(28.25) | 66(75.86) | 21(24.14) | ||
先前是否使用二线药物 | 0.027 | 0.870 | |||
是 | 28(9.09) | 7(25.00) | 21(75.00) | ||
否 | 280(90.91) | 74(26.43) | 206(73.57) |
变量 | β值 | s | Wald χ2值 | P值 | OR值(95%CI) |
---|---|---|---|---|---|
性别 | |||||
女性 | Ref | ||||
男性 | 1.057 | 0.384 | 7.582 | 0.006 | 2.877(1.356~6.104) |
年龄组(岁) | |||||
<50 | Ref | ||||
≥50 | 0.606 | 0.303 | 3.990 | 0.046 | 1.833(1.011~3.323) |
职业分类 | |||||
其他职业 | Ref | ||||
家务及待业 | -1.044 | 0.289 | 12.320 | 0.001 | 0.352(0.196~0.631) |
登记分类 | |||||
初治 | Ref | ||||
复治 | 1.850 | 0.632 | 8.561 | 0.003 | 6.357(1.842~21.944) |
3个月末痰培养 | |||||
阳性 | Ref | ||||
阴性 | 3.683 | 0.407 | 82.080 | <0.001 | 0.162(0.063~0.416) |
常数项 | -3.319 | 0.764 | 18.886 | <0.001 | 0.036 |
[1] | World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization, 2022. |
[2] | World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020. |
[3] |
Liu Z, Dong H, Wu B, et al. Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: A meta-analysis of findings. J Infect, 2019, 79(4):349-356. doi:10.1016/j.jinf.2019.08.004.
pmid: 31400354 |
[4] |
Furin J, Cox H, Pai M. Tuberculosis. Lancet, 2019, 393(10181):1642-1656. doi:10.1016/S0140-6736(19)30308-3.
pmid: 30904262 |
[5] |
Pan Y, Yu Y, Yi Y, et al. The differences in drug resistance between drug-resistant tuberculosis patients with and without diabetes mellitus in northeast China: a retrospective study. BMC Infect Dis, 2023, 23(1):162. doi:10.1186/s12879-023-08130-1.
pmid: 36922787 |
[6] |
Mukherjee JS, Rich ML, Socci AR, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet, 2004, 363(9407):474-481. doi:10.1016/S0140-6736(04)15496-2.
pmid: 14962530 |
[7] | 中华人民共和国国家卫生健康委员会. 中国结核病预防控制工作技术规范(2020年版). 国卫办疾控函〔2020〕279号. 2020-04-02. |
[8] |
Jain K, Desai M, Solanki R, Dikshit RK. Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis. J Pharmacol Pharmacother, 2014, 5(2):145-149. doi:10.4103/0976-500X.130062.
pmid: 24799815 |
[9] | Johnston JC, Shahidi NC, Sadatsafavi M, et al. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One, 2009, 4(9):e6914. doi:10.1371/journal.Pone.0006914. |
[10] |
Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax, 2006, 61(2):158-163. doi:10.1136/thx.2005.045963.
pmid: 16254056 |
[11] |
Duraisamy K, Mrithyunjayan S, Ghosh S, et al. Does Alcohol consumption during multidrug-resistant tuberculosis treatment affect outcome? A population-based study in Kerala, India. Ann Am Thorac Soc, 2014, 11(5):712-718. doi:10.1513/AnnalsATS.201312-447OC.
pmid: 24735096 |
[12] |
Jeon DS, Shin DO, Park SK, et al. Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector. J Korean Med Sci, 2011, 26(1):33-41. doi:10.3346/jkms.2011.26.1.33.
pmid: 21218027 |
[13] | 郝晓晖, 姚岚, 孙华, 等. 老年耐多药肺结核临床特征及转归分析. 中华结核和呼吸杂志, 2014, 37(3):188-191. doi:10.3760/cma.j.issn.1001-0939.2014.03.009. |
[14] | Yamaguchi Y, Kawabe Y, Nagayama N, et al. A study on the clinical features of pulmonary tuberculosis in elderly patients. Kekkaku, 2001, 76(6): 447-454. doi:10.11400/kekkaku1923.76.447. |
[15] |
Das SK, Mukherjee RS, Ghosh IN, et al. A study of pulmonary tuberculosis in the elderly. J Indian Med Assoc, 2007, 105(8):432-439.
pmid: 18236905 |
[16] | World Health Organization. Global tuberculosis report 2012. Geneva: World Health Organization, 2012. |
[17] |
Kwon YS, Chi SY, Oh IJ, et al. Clinical characteristics and treatment outcomes of tuberculosis in the elderly: a case control study. BMC Infect Dis, 2013, 13:121. doi:10.1186/1471-2334-13-121.
pmid: 23510403 |
[18] | 李硕兰, 李明武, 李光妹, 等. 中国耐多药肺结核不良治疗转归影响因素的Meta分析. 中国防痨杂志, 2022, 44(12):1303-1313. doi:10.19982/j.issn.1000-6621.20220212. |
[19] | 张梦娴, 杨成凤, 叶建君, 等. 1447例耐多药肺结核患者治疗转归队列分析. 公共卫生与预防医学, 2020, 31(3):68-72. doi:10.3969/j.issn.1006-2483.2020.03.017. |
[20] | 徐彩红, 张慧, 阮云洲, 等. 我国六省(自治区)全球基金项目地区耐多药肺结核诊疗效果的回顾性分析. 中国防痨杂志, 2018, 40(6):559-563. doi:10.3969/j.issn.1000-6621.2018.06.003. |
[21] | 王坚杰, 易凤莲, 陈聪, 等. 团体心理辅导对耐多药结核病患者的抑郁症状干预效果. 公共卫生与预防医学, 2017, 28(1):50-52. |
[22] | 唐神结, 肖和平, 张青. 耐多药结核病化疗研究的新进展. 中华结核和呼吸杂志, 2009, 32(8):617-620. doi:10.3760/cma.j.issn.1001-0939.2009.08.019. |
[23] | 杨超, 王晶, 唐桂林, 等. 2016—2020年北京市通州区病原学阴性肺结核流行特征及治疗转归分析. 结核与肺部疾病杂志, 2022, 3(6):477-482. doi:10.19983/j.issn.2096-8493.20220149. |
[24] | 何伏华, 冯地忠, 丁守华. 2013—2017年淮安市菌阴肺结核流行特征分析. 中国校医, 2019, 33(3):196-197,204. |
[25] | 雷蓉蓉, 汪清雅, 张婷. 重庆市肺结核患者复发情况及影响因素分析. 中国热带医学, 2020, 20(11):1092-1095. doi:10.13604/j.cnki.46-1064/r.2020.11.16. |
[26] | 戴志松, 陈堃, 林淑芳, 等. 福建省成功治疗的肺结核患者10年复发情况及影响因素分析. 疾病监测, 2021, 36(11):1152-1158. doi:10.3784/jbjc.202106300378. |
[27] |
Liu Q, Lu P, Martinez L, et al. Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China. BMC Infect Dis, 2018, 18(1):114. doi:10.1186/s12879-018-3021-0.
pmid: 29510666 |
[28] |
Nagaraja C, Shashibhushan BL, Asif M, et al. Pattern of drug-resistance and treatment outcome in multidrug-resistant pulmonary tuberculosis. Indian J Chest Dis Allied Sci, 2012, 54(1):23-26.
pmid: 22779119 |
[29] |
Jain K, Desai M, Solanki R, et al. Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis. J Pharmacol Pharmacother, 2014, 5(2):145-149. doi:10.4103/0976-500X.130062.
pmid: 24799815 |
[30] |
Holtz TH, Sternberg M, Kammerer S, et al. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Ann Intern Med, 2006, 144(9):650-659. doi:10.7326/0003-4819-144-9-200605020-00008.
pmid: 16670134 |
[31] |
Kurbatova EV, Gammino VM, Bayona J, et al. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis, 2012, 16(10):1335-1343. doi:10.5588/ijtld.11.0811.
pmid: 23107633 |
[32] |
Kurbatova EV, Cegielski JP, Lienhardt C, et al. Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies. Lancet Respir Med, 2015, 3(3):201-209. doi:10.1016/S2213-2600(15)00036-3.
pmid: 25726085 |
[33] | Basit A, Ahmad N, Khan AH, et al. Predictors of two months culture conversion in multidrug-resistant tuberculosis: findings from a retrospective cohort study. PLoS One, 2014, 9(4):e93206. doi:10.1371/journal.pone.0093206. |
[34] |
Singla R, Sarin R, Khalid UK, et al. Seven-year DOTS-Plus pilot experience in India: results, constraints and issues. Int J Tuberc Lung Dis, 2009, 13(8):976-981.
pmid: 19723377 |
[35] |
Rodriguez M, Monedero I, Caminero JA, et al. Successful management of multidrug-resistant tuberculosis under programme conditions in the Dominican Republic. Int J Tuberc Lung Dis, 2013, 17(4):520-525. doi:10.5588/ijtld.12.0481.
pmid: 23485386 |
[36] | 林志浩, 丘小燕, 马晓慧, 等. 佛山市193例耐多药肺结核患者的治疗转归及影响因素分析. 实用预防医学, 2022, 29(11):1290-1294. |
[1] | You Guoqing, Liu Wenguo, Feng Xin, Yu Min, Shi Lin, Hu Yan. Analysis of fluoroquinolones resistance in multidrug-resistant tuberculosis patients in Chongqing from 2020 to 2022 [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 475-479. |
[2] | Wang Yuxiang, Hu Qiumeng, Zheng Junfeng, Deng Guofang, Zhang Peize. Analysis of clinical characteristics and prognosis of pulmonary diseases caused by Mycobacterium kansassi and Mycobacterium intracellular [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 480-485. |
[3] | Ma Jianjun, Zhang Tiejuan, Zhao Qinglong, Yu Shihui, Mei Yang. Random forest algorithm-based study of risk factors for tuberculosis incidence in an elderly mobile population [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(5): 364-369. |
[4] | Yang Liangzi, Wang Yuxiang, Tan Jie, Zheng Junfeng, Fu Liang, Deng Guofang, Zhang Peize. Analysis of influencing factors of delayed negative conversion of sputum bacteria in drug sensitive pulmonary tuberculosis patients with diabetes during intensive treatment [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(5): 370-375. |
[5] | Yang Chao, Wang Jing, Xie Ke, Tang Guilin. Analysis of the treatment outcome and influencing factors of pulmonary tuberculosis patients in floating population in Tongzhou District of Beijing, 2012—2021 [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(5): 376-382. |
[6] | Zhang Ying, Lao Haijun, Lin Bing, Liu Junting, Sun Dongmei. Analysis of diagnosis and treatment of 76 cases of chronic tuberculous empyema treated by complete thoracoscopy with process optimization method [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(4): 308-312. |
[7] | Zhou Lin, Liu Eryong, Zhao Yanlin. Select appropriate treatment plan and correctly evaluate the efficacy of anti-tuberculosis treatment, improving the treatment quality of rifampicin sensitive tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(3): 189-193. |
[8] | Yang Chao, Wang Jing, Xie Ke, Tang Guilin, Gao Hanqing, Wang Bin. Analysis of the epidemiological characteristics and treatment outcomes of pulmonary tuberculosis with positive etiology in Tongzhou, Beijing from 2012 to 2021 [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(2): 128-134. |
[9] | Zhang Yajing, Jiang Ying, Sun Hao, Tang Guiqin, Zhao Ying. Analysis of detection and treatment prognosis of 154 elderly pulmonary tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(1): 48-53. |
[10] | Guo Qiang, Li Ruiping, Ma Yubao, Zhang Lan, Yang Shumin. Analysis of treatment adverse outcomes for rifampicin sensitive pulmonary tuberculosis patients with random effects logistic model in Gansu Province from 2018 to 2020 [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(6): 455-462. |
[11] | Huang Yao, Fan Yuzheng, Wang Xiangyu, Zhong Tao, Zhang Jie, Yang Nansen, Li Shengbin, Ye Xuetian, Liu Shengyuan. Analysis of management and treatment effects of pulmonary tuberculosis patients in Nanshan District, Shenzhen City, 2011—2020 [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(6): 463-468. |
[12] | Chen Zidan, Mao Ling. Clinical analysis of 28 cases of artificial stone associated silicosis complicated with pulmonary tuberculosis and non-tuberculous mycobacteria disease [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(5): 388-393. |
[13] | Dong Zhaoliang, Yao Liming, Li Lingdi, Wang Lianbo, Yao Xiaowei, Li Zhuo, Liu Fengsheng, Jia Chenguang. Clinical efficacy of conservative treatment for mild spinal tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(4): 281-286. |
[14] | Li Yishuai, Qin Xuebo, Li Xianglan, Wei Lan, Duan Xiaoliang, Zhang Lei, Chen Liang, Li Jianhang. Analysis of effect of video-assisted thoracoscopic surgery versus thoracotomy in the treatment of refractory cavity pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(4): 292-295. |
[15] | Xin Chaojun, Cao lijing, Lyu Lige. Analysis of risk factors of recurrent respiratory tract infections in children [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(4): 300-304. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||